WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
SHANGHAI and LEVERKUSEN – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer jointly announced an acquisition agreement that WuXi Biologics Germany GmbH will take over the operations of one of Bayer’s final drug product manufacturing plants in Leverkusen, Germany, and purchase the associated equipment, in combination with a long-term lease contract for the building.
Based on a manufacturing agreement to be negotiated, the plant would be operated by WuXi Biologics and serve as a back-up site for the final product manufacturing of Kovaltry™, an antihemophilic factor (recombinant). The transaction is expected to be concluded in the coming months subject to the satisfaction of customary closing conditions. Financial details were not disclosed.
“We are excited to sign this acquisition agreement with Bayer, allowing us to have quick access to high quality drug product manufacturing capacities and capabilities,” said Dr. Chris Chen, CEO of WuXi Biologics. “Our business in EU, US and China market has experienced robust growth in the past few years. This additional drug product plant further confirms our commitment to ‘Global Dual Sourcing within WuXi Biologics’ strategy. WuXi Biologics will continue to expand our worldwide capacity, providing global partners with a robust and premier-quality supply chain network to benefit patients worldwide.”
Countries
Companies
Latest news
BASF, SABIC, and Linde celebrate the start-up of the world's first large-scale electrically heated steam cracking furnace at Ludwigshafen demoplant, Germany
BASF SE, Ludwigshafen →Demonstration plant with 6 megawatts input of renewable electrical energy to test material behavior and process on an industrial scale. Joint development and construction of electric steam cracking...
Topsoe to supply technology for Cepsa's 2G biofuels plant in Palos de la Frontera, Spain
Cepsa and Bio-Oils’ new plant will begin production in 2026 and is expected to produce 500,000 tons of Sustainable Aviation Fuel (SAF) and renewable diesel annually. Topsoe will deliver its HydroFl...
BASF has successfully started operating its prototype metal refinery for battery recycling in Schwarzheide, Germany
Innovative technology extracts lithium, nickel, cobalt, manganese and copper from end-of-life lithium-ion batteries and battery production scrap. Plant represents further milestone in building Euro...
Mol inaugurates the largest green hydrogen plant of the region at the Danube Refinery in Százhalombatta, Hungary
MOL produces 1600 tonnes of green hydrogen per year using electricity from renewable sources. The plant will reduce carbon dioxide emissions of the Danube Refinery by 25 000 tonnes. With the introd...